Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis

Mark C. Genovese, Josef S. Smolen, Tsutomu Takeuchi, Gerd Burmester, Dennis Brinker, Terence P. Rooney, Jinglin Zhong, Mo Daojun, Chadi Saifan, Anabela Cardoso, Maher Issa, Wen Shuo Wu, Kevin L. Winthrop